期刊论文

中文

成都中医药大学学报

1004-0668

2006

29

2

1-5

10.3969/j.issn.1004-0668.2006.02.001

国家“十五”科技攻关课题（任务编号:2001BA701A13a）；

本校为其他机构

目的：初步评价中药复方芪明颗粒治疗糖尿病视网膜病变（DR）非增殖期的有效性和安全性。方法：采用双盲双模拟、随机对照、多中心临床试验研究方法，在5家医院收集212例DR患者，试验组（芪明颗粒）107例，对照组（导升明胶囊）105例，疗程3个月，治疗结束后以眼底检查、眼底荧光血管造影、视力等指标综合评价疗效，同时检测、血、尿便常规及心电图、肝肾功能等安全性指标。结果：试验组显效率40．2％，总有效率81．3％；对照组显效率29．5％，总有效率71．4％，两组疾病疗效相当（P〉0．05）。中医证候试验组显效率28．0％，总有效率75．7％；对照组显效率12．4％，总有效率59．0％。试验组疗效...

Objective： To evaluate the efficacy and salty of the Qi-ming granule in treatment of non-proliferative diabetic retinopathy （DR）. Methods： Designing randomized parallel multicentric clinical trail, There are 212 eyes of 212 patients with non-proliferative DR who were enrolledand treated in the 5 medical centers with the same inclusion and exclusion criteria, Qi-ming granule group 107, Doxium-controlled group 105. Patients received periodic detailed ophthalmic examinations with fundus photography, fundus fluorescein angiography, symptom of T...